期刊文献+

全身PET/CT显像对非小细胞肺癌纵隔淋巴结转移的诊断价值 被引量:1

Value of Whole Body PET/CT Imaging in the Diagnosis of Mediastinal Lymph Node Metastasis in Non Small Cell Lung Cancer
下载PDF
导出
摘要 目的探讨全身PET/CT显像对非小细胞肺癌(NSCLC)纵隔淋巴结转移的诊断价值。方法对85例NSCLC患者的临床资料作回顾性分析,术前均行PET/CT检查,并行手术根治或纵隔淋巴结活检。结果病理结果示23例发生淋巴转移,阳性率为27.1%。PET/CT对纵隔淋巴结转移的灵敏度为82.6%,特异度为90.3%,阳性预测值为76%,阴性预测值为93.3%,准确性为88.2%。结论PET/CT对纵隔淋巴结转移的特异度及阴性预测值较高,但灵敏度及阳性预测值欠佳,提示PET/CT检出为阳性的淋巴结需进一步行纵隔镜检查。 Objective To investigate the value of whole body PET/CT imaging in the diagnosis of mediastinal lymph node metastasis of non small cell lung cancer(NSCLC). Methods The clinical data of 85 patients with NSCLC were retrospectively analyzed. All patients underwent PET/CT examination before operation, and underwent radical or mediastinal lymph node biopsy. Results Pathological results showed that 23 cases had lymph node metastasis, the positive rate was 27.1%. The sensitivity of PET/CT to mediastinal lymph node metastasis was 82.6%, the specificity was 90.3%, the positive predictive value was 76%, the negative predictive value was 93.3%, the accuracy was 88.2%. Conclusion The specificity and negative predictive value of PET/CT for mediastinal lymph node metastasis were higher, but the sensitivity and positive predictive value were not well. It was suggested that PET/CT was positive for lymph nodes to be further performed in the diagnosis of mediastinal lymph node.
出处 《中国继续医学教育》 2016年第27期33-34,共2页 China Continuing Medical Education
关键词 PET/CT显像 非小细胞肺癌 纵隔淋巴结转移 PET/CT imaging Non small cell lung cancer Mediastinal lymph node metastasis
  • 相关文献

参考文献8

二级参考文献81

  • 1徐晓庆,于金明.^(18)F-FDG PET对非小细胞肺癌预后预测价值的研究进展[J].中华肿瘤防治杂志,2008,15(12):955-958. 被引量:7
  • 2何胜利,管一晖,赵军,左传涛,董竞成.^(18)F-FDG标准摄取值对非小细胞肺癌预后的影响[J].中国肿瘤临床,2006,33(3):167-170. 被引量:9
  • 3杨文锋,付政,于金明,王绍平,房玉芳,袁方,穆殿斌.^(18)F-FDG PET/CT对非小细胞肺癌区域淋巴结诊断的假阴性与假阳性研究[J].中华核医学杂志,2007,27(3):139-142. 被引量:12
  • 4Goldstraw P. The 7th Edition of TNM in Lung Cancer: what now J 3. J Thorac Oncol, 2009, 4(6): 671-3.
  • 5Kligerman S, Digumarthy S. Staging of non-small cell lung cancer using integrated PET/CT[J ]. Am J Roentgenol, 2009, 193(5):1203 - 11.
  • 6West H, Harpole D, Travis W. Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer[J]. Chest, 2009, 136(4): 1112-8.
  • 7Sanli M, Isik AF, Zincirkeser S, et al. Reliability of positron emission tomog raphy-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2009, 138(5): 1200-5.
  • 8Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediast inal staging in patients with non-small-cell lung cancer: a meta analysis[J]. Ann Intern Med, 2003, 139: 879-92.
  • 9Weng E, Tran L, Rege S, et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer[J]. Am J Clin Oncol, 2000, 23:47-52.
  • 10Kelly RF, Tran T, Holmstrom A, et al. Accuracy and cost- effectiveness of [ ^18F ]-2-fluoro deoxy-D- glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer [J]. Chest, 2004, 125: 413-23.

共引文献47

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部